Relmada Therapeutics, Inc. RLMD Investment Income Interest
Investment Income Interest at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Relmada Therapeutics, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s investment income interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s investment income interest?
- Relmada Therapeutics, Inc. (RLMD) reported investment income interest of $959.76K in Q1 2026.
- How has Relmada Therapeutics, Inc.'s investment income interest changed year-over-year?
- Relmada Therapeutics, Inc.'s investment income interest increased by 118.0% year-over-year, from $440.29K to $959.76K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s investment income interest?
- Over 2 years (2023 to 2025), Relmada Therapeutics, Inc.'s investment income interest has grown at a -47.9% compound annual growth rate (CAGR), from $5.15M to $1.4M.
- What does investment income interest mean?
- Reflects the interest income generated from cash, cash equivalents, and marketable securities held by the company. This serves as a secondary source of liquidity that helps offset a portion of the company's operating cash burn.